Why These 15 Biotech Stocks Are Skyrocketing So Far In 2025
No matter the market environment, you’ll always find entertainment in the biotech space.
No. | Hedge Fund | Shares | Value | Activity | % Port |
---|---|---|---|---|---|
1. | Siren L.L.C. Raymond Debbane | 1,967,064 | $3,501,374 | -2% | 0.2% |
2. | Renaissance Technologies Jim Simons | 219,400 | $390,532 | -41% | 0% |
Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|
$1.71 | 12,000 | 12,000 | 2024-12-19 | Filing | ||
$1.68 | 5,000 | 222,687 | 2024-12-19 | Filing | ||
$1.67 | 5,000 | 217,687 | 2024-12-18 | Filing | ||
$2.34 | 5,000 | 212,687 | 2024-12-05 | Filing | ||
$3.75 | 4,000 | 207,687 | 2023-11-20 | Filing |
Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|
$14.00 | 300 | Officer | 4,000 | 2022-11-18 | Filing |
No. | Name | Shares | Value | % Port |
---|---|---|---|---|
1. | 1,724,520 | $3,069,646 | 0.01% | |
2. | 1,048,823 | $1,866,905 | 0% | |
3. | 1,033,577 | $1,839,767 | 0.01% | |
4. | 419,145 | $746,078 | 0% | |
5. | 244,534 | $435,343 | 0% |